Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...
The FDA approved Nufymco as an interchangeable biosimilar to Lucentis, making it the second approved ranibizumab biosimilar ...
Calling eye drops “artificial tears” can mislead people into thinking the drops are more sophisticated than they truly are ...
ORLANDO — Children and adolescents with food allergy often experience substantial fear of negative social evaluation, ...
Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...
Self-reported knee crepitus may predict osteoarthritis 1 year following ACL reconstruction, according to findings published ...
The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with ...
Autoantibody positivity rates were lower in people with dermatomyositis who used immunostimulatory herbs before disease onset ...
Among pediatric and adult patients with cystic fibrosis, the average number of chronic respiratory therapies used fell after ...
Lewiss on Lifestyle MedicineThe U.S. physical activity guidelines recommend that healthy adults, including elderly, get at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of ...
In this interview Ira Zackon, MD, highlights data on bispecific antibody use in patients with multiple myeloma in the community setting as presented at ASH 2025.
In this interview Shahzad Raza, MD, discusses a study on the treatment of patients with extramedullary myeloma, as presented at ASH 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback